Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US4050241003
Ticker HAE
Company HAEMONETICS
Currency $
Price
Aware Investor Index (AII) 0.0002
Recommendation STRONG SELL
P/E 143.85
ROE 4.24 %
Capitalization 4,590,385,800 $
Dividend Yield 0.00 %
P/S 5.08
AII Position 703
P/E Position 718
ROE Position 655
Capitalization Position 568
Dividend Yield Position 596
Sales 903,923,000 $
10-Year Average Earnings 31,911,000 $
Shares Outstanding 53,501,000
Equity 752,429,000 $
Dividend per Share 0 $
Industry Medical Equipment
Country United States
HAEMONETICS Investor Relations Web Site http://www.haemonetics.com/About.aspx







Sales:

YEAR MONTH AMOUNT
2018 3 903,923,000.00 $
2017 3 886,116,000.00 $
2016 3 908,832,000.00 $
2015 3 910,373,000.00 $
2014 3 938,509,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 3 45,572,000.00 $
2017 3 -26,268,000.00 $
2016 3 -55,579,000.00 $
2015 3 16,897,000.00 $
2014 3 35,148,000.00 $
2013 3 38,800,000.00 $
2012 3 66,886,000.00 $
2011 3 79,980,000.00 $
2010 3 58,370,000.00 $
2009 3 59,304,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 3 752,429,000.00 $
2017 3 739,610,000.00 $
2016 3 721,565,000.00 $
2015 3 826,122,000.00 $
2014 3 837,888,000.00 $
2013 3 769,182,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 3 53,501,000
2017 3 51,524,000
2016 3 50,910,000
2015 3 52,089,000
2014 3 52,377,000
2013 3 52,259,000

 












Bloomberg News for HAEMONETICS:



Google News for HAEMONETICS:

Seeking Alpha - 5 Feb 2019
Haemonetics Corporation (HAE) CEO Chris Simon on Q3 2019 ...
Haemonetics Corporation (NYSE:HAE) Q3 2019 Results Conference Call February 5, 2019 8:00 AM ET. Company Participants. Olga Vlasova - ...
Motley Fool
Haemonetics Corp (HAE) Shareholder Copper Rock Capital ...
Haemonetics Corp (HAE) Shareholder Copper Rock Capital Partners LLC Has Lowered Position by $14.24 Million as Share Value Declined.
Thorold News - 11 hours ago
Haemonetics (HAE) Earnings Top, Revenues Lag Estimates in Q3
Haemonetics Corporation HAE reported adjusted earnings per share (EPS) of 63 cents in the third quarter of fiscal 2019, reflecting a ...
BharataPress
Are Haemonetics Corporation's (NYSE:HAE) Returns Worth Your ...
Today we'll look at Haemonetics Corporation (NYSE:HAE) and reflect on its potential as an investment. To be precise, we'll consider its Return ...
Standard Recorder
Haemonetics (HAE) Q3 Earnings Surpass Estimates
Haemonetics, which belongs to the Zacks Medical - Products industry, posted revenues of $247.36 million for the quarter ended December ...
The Yomi Blog (blog)
Consolidated Research: 2019 Summary Expectations for Corning ...
To read the full Haemonetics Corporation (HAE) report, download it here: http://MarketSourceResearch.com/register/?so=HAE.
Nasdaq - 6 Feb 2019
Haemonetics $HAE Technical Update
The Haemonetics (NYSE: HAE) update and the technical summary table below can help you manage risk and optimize returns. We have day ...
Simply Wall St - 2 days ago
Schafer Cullen Capital Management Upped By $662155 Its ...
Chicago Equity Partners Llc decreased Haemonetics Corp (HAE) stake by 45.76% reported in 2018Q3 SEC filing. Chicago Equity Partners Llc ...
Zacks.com - 5 Feb 2019
Haemonetics (HAE) Posts Quarterly Earnings Results, Beats ...
Haemonetics (NYSE:HAE) posted its quarterly earnings data on Tuesday, February 5th. The medical instruments supplier reported $0.63 ...
Seeking Alpha
Haemonetics (HAE) Releases FY 2019 Earnings Guidance
Haemonetics (NYSE:HAE) updated its FY 2019 earnings guidance on Tuesday. The company provided earnings per share guidance of ...


Back